+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gastrointestinal Bleeding Treatment Devices Market by Product Type, Technology, Application, End User, Indication Type - Global Forecast to 2030- Product Image
Gastrointestinal Bleeding Treatment Devices Market by Product Type, Technology, Application, End User, Indication Type - Global Forecast to 2030- Product Image
Sale

Gastrointestinal Bleeding Treatment Devices Market by Product Type, Technology, Application, End User, Indication Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 195 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6016535
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Gastrointestinal Bleeding Treatment Devices Market grew from USD 559.43 million in 2024 to USD 590.93 million in 2025. It is expected to continue growing at a CAGR of 5.37%, reaching USD 765.86 million by 2030.

Understanding the Gastrointestinal Bleeding Treatment Landscape

Gastrointestinal bleeding remains a critical clinical challenge, affecting millions of patients worldwide and demanding prompt, effective intervention. Bleeding may originate from upper or lower segments of the digestive tract and can stem from peptic ulcers, variceal hemorrhages, Dieulafoy lesions, Mallory-Weiss tears or angiodysplasia. Without reliable hemostatic solutions, clinicians face heightened risks of morbidity, prolonged hospital stays and increased procedural costs. As end users seek minimally invasive, high-efficacy treatments, the evolution of device portfolios has become a strategic imperative for manufacturers and healthcare providers alike.

This executive summary synthesizes the latest advances in gastrointestinal bleeding treatment devices, offering a holistic view of emerging technologies, shifting policy environments and evolving patient profiles. By distilling insights from primary interviews with key opinion leaders, rigorous secondary research and regional market intelligence, our analysis illuminates the forces shaping procurement decisions and investment priorities. Stakeholders will gain clarity on competitive dynamics, regulatory catalysts and actionable pathways to optimize market positioning.

Innovations Reshaping Gastrointestinal Bleeding Management

Over the past decade, transformative breakthroughs in hemostatic agents have redefined procedural efficacy, enabling endoscopists to achieve rapid bleeding control with powders that adhere to irregular mucosal surfaces and sheets engineered for targeted application. Simultaneously, advanced endoscopic clips equipped with enhanced torque and rotational capabilities have improved tissue approximation in challenging anatomic locations. Thermal coagulation devices have evolved through refined argon plasma technology and next-generation bipolar and heater probes, delivering controlled energy dispersion while minimizing collateral injury. Together, these innovations have elevated procedural success rates and expanded the therapeutic toolkit for acute hemorrhage management.

Beyond device evolution, integrated digital platforms now support real-time visualization, automated lesion-detection algorithms and remote proctoring, augmenting clinical decision-making and accelerating training cycles. Radiologic interventions such as angiographic embolization benefit from advances in microcatheter design and embolic materials, while surgical approaches leverage both laparoscopic and open techniques refined through robotic assistance and enhanced imaging. These shifts underscore a broader trend toward personalized, multimodal bleeding control pathways that align with patient risk profiles and institutional capabilities.

Evaluating the Ramifications of New U.S. Tariffs in 2025

In early 2025, newly enacted U.S. tariffs on a range of imported medical devices introduced additional import duties that directly affect manufacturers of gastrointestinal bleeding treatment systems. These measures aim to incentivize domestic production and rebalance trade deficits, yet they also introduce higher landed costs for devices that rely on complex global supply chains. Companies heavily dependent on overseas component sourcing must now reassess vendor agreements and identify alternate manufacturing hubs to preserve margin structures.

As pricing pressures mount, providers face potential budgetary constraints that could decelerate capital procurement cycles or drive demand toward lower-cost alternatives. Forward-looking firms have begun mitigating tariff-driven cost inflation by onshoring key production lines, renegotiating distribution contracts and accelerating investments in local assembly facilities. While these strategies require upfront capital outlays, they offer a sustainable path to cost containment and supply chain resilience in the face of evolving trade policies.

In-Depth Analysis of Market Segmentation Dynamics

Market participants categorize gastrointestinal bleeding treatment devices according to product type and technology in order to align R&D priorities and deployment strategies. Product modalities span endoscopic clips alongside hemostatic agents in powder, sheet, and spray formulations, injection therapies such as alcohol sclerosant, epinephrine and polidocanol, and thermal devices ranging from argon plasma coagulation to bipolar probes and heater probes. Layered upon these offerings is the choice of technology, with clinicians selecting between flexible or rigid endoscopy, radiologic approaches encompassing angiographic embolization and mesenteric stenting, and surgical pathways that include laparoscopic and open procedures.

Application-based segmentation further refines market positioning by focusing on clinical indications such as angiodysplasia, Dieulafoy lesion, Mallory-Weiss tear, peptic ulcer bleeding and variceal hemorrhage. End users vary from ambulatory surgical centers to specialized gastroenterology clinics, as well as inpatient and outpatient hospital settings, each with distinct purchasing cycles, reimbursement models and procedural volumes. Indication types bifurcate into lower gastrointestinal categories of colonic and rectal bleeding alongside upper gastrointestinal classifications of duodenal, esophageal and gastric hemorrhages. Understanding these intersecting dimensions empowers manufacturers to tailor product portfolios, channel strategies and clinical education programs in alignment with nuanced market needs.

Regional Market Distinctions Driving Strategic Priorities

The Americas continue to lead adoption of advanced hemostatic solutions, underpinned by robust reimbursement frameworks, high procedural volumes and an active culture of clinical research. The United States in particular drives demand for minimally invasive devices, incentivizing innovation partnerships and attracting capital investment in distribution networks. Patient awareness and provider training initiatives further accelerate uptake, while domestic production incentives respond to tariff pressures and supply chain optimization efforts.

In Europe, the Middle East and Africa, regulatory harmonization and value-based procurement models are reshaping purchasing behaviors. Emerging markets within this region show growing appetite for cost-effective yet high-performance treatment options, prompting tiered product launches and strategic alliances. Simultaneously, stringent regulatory oversight fosters collaboration between manufacturers and health technology assessment bodies to demonstrate clinical and economic value. Across Asia-Pacific, dynamic growth stems from rising healthcare expenditures, expanding hospital networks and an increasing focus on disease management infrastructure. Local manufacturing partnerships and technology transfers have become critical to meeting demand in densely populated markets, facilitating broader access to next-generation bleeding control devices.

Competitive Intelligence on Leading Industry Players

Leading companies in this space differentiate themselves through continuous product innovation, strategic acquisitions and broad clinical support programs. Established medical device corporations leverage deep R&D pipelines to expand their hemostatic portfolios, integrating novel biomaterials and energy-delivery mechanisms. Concurrently, high-growth challengers emphasize nimble development cycles, rapid regulatory clearances and targeted geographic expansions to capture underserved segments.

Partnerships between device manufacturers and academic institutions have emerged as a pivotal driver of evidence generation, enabling landmark clinical trials and peer-reviewed publications that reinforce product adoption. Meanwhile, collaboration with distributor networks ensures broad market reach and localized customer service. Companies are also investing in digital education platforms and remote training modules, delivering real-time procedural support to clinicians and fostering brand loyalty through value-based engagement.

Strategic Imperatives for Market Leadership

To secure leadership positions, firms must intensify investment in next-generation hemostatic chemistries, leverage artificial intelligence to enhance endoscopic guidance, and accelerate development of multifunctional devices capable of addressing complex bleeding scenarios. Establishing regional manufacturing hubs can mitigate tariff impacts while fostering close collaboration with local stakeholders and streamlining logistics. Cultivating strategic alliances with hospital systems and ambulatory centers will facilitate early adoption of novel therapies and support iterative feedback loops for product refinement.

Furthermore, companies should enhance their market access capabilities by generating real-world evidence that underscores clinical and economic benefits. Engaging with regulatory agencies proactively to expedite approvals, and embedding digital training modules within product ecosystems, will strengthen stakeholder confidence. By aligning product development with the unique requirements of varied end users and indication types, organizations can craft differentiated value propositions that resonate across the continuum of gastrointestinal care.

Robust Methodology Underpinning the Market Study

This analysis harnessed a dual approach of primary and secondary research to ensure comprehensive coverage and accuracy. Primary data collection involved structured interviews with key opinion leaders, including gastroenterologists, interventional radiologists and procurement specialists, to capture real-world insights on device performance and adoption barriers. Secondary research integrated peer-reviewed literature, patent filings, regulatory databases and corporate filings to validate competitive and technological trends.

Data triangulation and rigorous cross-verification methods were employed to reconcile divergent sources and ensure robust findings. Segmentation frameworks were iteratively refined through quantitative modeling and qualitative validation, while regional market analyses incorporated local regulatory guidelines, reimbursement policies and stakeholder interviews. This systematic methodology underpins the credibility of our conclusions and provides a transparent foundation for strategic decision-making.

Final Takeaways on Gastrointestinal Bleeding Treatment Innovations

The gastrointestinal bleeding treatment landscape stands at an inflection point, driven by pioneering hemostatic agents, advanced endoscopic tools and integrated digital platforms. Adaptive strategies to navigate evolving trade policies, particularly the 2025 U.S. tariffs, will separate market leaders from laggards. In parallel, nuanced insights into product, technology, application and end-user segments enable precise targeting of investment and commercial efforts.

By aligning clinical innovation with regional market dynamics and regulatory imperatives, stakeholders can capitalize on growth opportunities and deliver superior patient outcomes. This executive summary equips decision-makers with a clear blueprint to refine their portfolios, optimize supply chains and fortify their competitive edge in the rapidly advancing field of gastrointestinal bleeding management.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Endoscopic Clips
    • Hemostatic Agents
      • Powder
      • Sheets
      • Spray
    • Injection Therapy
      • Alcohol Sclerosant
      • Epinephrine
      • Polidocanol
    • Thermal Devices
      • Argon Plasma Coagulation
      • Bipolar Probes
      • Heater Probes
  • Technology
    • Endoscopic
      • Flexible Endoscopy
      • Rigid Endoscopy
    • Radiologic
      • Angiographic Embolization
      • Mesenteric Stenting
    • Surgical
      • Laparoscopic Surgery
      • Open Surgery
  • Application
    • Angiodysplasia
    • Dieulafoy Lesion
    • Mallory-Weiss Tear
    • Peptic Ulcer
    • Variceal Bleeding
  • End User
    • Ambulatory Surgical Centers
    • Gastroenterology Clinics
    • Hospitals Inpatient
    • Hospitals Outpatient
  • Indication Type
    • Lower GI
      • Colonic Bleeding
      • Rectal Bleeding
    • Upper GI
      • Duodenal Bleeding
      • Esophageal Bleeding
      • Gastric Bleeding
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Boston Scientific Corporation
  • Medtronic plc
  • Olympus Corporation
  • FUJIFILM Holdings Corporation
  • HOYA Corporation
  • Cook Medical LLC
  • Johnson & Johnson
  • B. Braun Melsungen AG
  • Teleflex Incorporated
  • ConMed Corporation

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Gastrointestinal Bleeding Treatment Devices Market, by Product Type
8.1. Introduction
8.2. Endoscopic Clips
8.3. Hemostatic Agents
8.3.1. Powder
8.3.2. Sheets
8.3.3. Spray
8.4. Injection Therapy
8.4.1. Alcohol Sclerosant
8.4.2. Epinephrine
8.4.3. Polidocanol
8.5. Thermal Devices
8.5.1. Argon Plasma Coagulation
8.5.2. Bipolar Probes
8.5.3. Heater Probes
9. Gastrointestinal Bleeding Treatment Devices Market, by Technology
9.1. Introduction
9.2. Endoscopic
9.2.1. Flexible Endoscopy
9.2.2. Rigid Endoscopy
9.3. Radiologic
9.3.1. Angiographic Embolization
9.3.2. Mesenteric Stenting
9.4. Surgical
9.4.1. Laparoscopic Surgery
9.4.2. Open Surgery
10. Gastrointestinal Bleeding Treatment Devices Market, by Application
10.1. Introduction
10.2. Angiodysplasia
10.3. Dieulafoy Lesion
10.4. Mallory-Weiss Tear
10.5. Peptic Ulcer
10.6. Variceal Bleeding
11. Gastrointestinal Bleeding Treatment Devices Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Gastroenterology Clinics
11.4. Hospitals Inpatient
11.5. Hospitals Outpatient
12. Gastrointestinal Bleeding Treatment Devices Market, by Indication Type
12.1. Introduction
12.2. Lower GI
12.2.1. Colonic Bleeding
12.2.2. Rectal Bleeding
12.3. Upper GI
12.3.1. Duodenal Bleeding
12.3.2. Esophageal Bleeding
12.3.3. Gastric Bleeding
13. Americas Gastrointestinal Bleeding Treatment Devices Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Gastrointestinal Bleeding Treatment Devices Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Gastrointestinal Bleeding Treatment Devices Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Boston Scientific Corporation
16.3.2. Medtronic plc
16.3.3. Olympus Corporation
16.3.4. FUJIFILM Holdings Corporation
16.3.5. HOYA Corporation
16.3.6. Cook Medical LLC
16.3.7. Johnson & Johnson
16.3.8. B. Braun Melsungen AG
16.3.9. Teleflex Incorporated
16.3.10. ConMed Corporation
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET MULTI-CURRENCY
FIGURE 2. GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET MULTI-LANGUAGE
FIGURE 3. GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC CLIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SHEETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SPRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ALCOHOL SCLEROSANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY EPINEPHRINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY POLIDOCANOL, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ARGON PLASMA COAGULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY BIPOLAR PROBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEATER PROBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RIGID ENDOSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ANGIOGRAPHIC EMBOLIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY MESENTERIC STENTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LAPAROSCOPIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ANGIODYSPLASIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DIEULAFOY LESION, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY MALLORY-WEISS TEAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PEPTIC ULCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY VARICEAL BLEEDING, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY GASTROENTEROLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS INPATIENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS OUTPATIENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COLONIC BLEEDING, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RECTAL BLEEDING, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DUODENAL BLEEDING, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ESOPHAGEAL BLEEDING, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY GASTRIC BLEEDING, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 85. CANADA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 86. CANADA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2030 (USD MILLION)
TABLE 87. CANADA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, 2018-2030 (USD MILLION)
TABLE 88. CANADA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, 2018-2030 (USD MILLION)
TABLE 89. CANADA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 90. CANADA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 91. CANADA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, 2018-2030 (USD MILLION)
TABLE 92. CANADA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 93. CANADA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. CANADA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. CANADA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 96. CANADA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, 2018-2030 (USD MILLION)
TABLE 97. CANADA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, 2018-2030 (USD MILLION)
TABLE 98. MEXICO GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 99. MEXICO GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2030 (USD MILLION)
TABLE 100. MEXICO GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, 2018-2030 (USD MILLION)
TABLE 101. MEXICO GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, 2018-2030 (USD MILLION)
TABLE 102. MEXICO GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 103. MEXICO GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 104. MEXICO GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, 2018-2030 (USD MILLION)
TABLE 105. MEXICO GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 106. MEXICO GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. MEXICO GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. MEXICO GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 109. MEXICO GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, 2018-2030 (USD MILLION)
TABLE 110. MEXICO GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, 2018-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, 2018-2030 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, 2018-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 152. UNITED KINGDOM GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, 2018-2030 (USD MILLION)
TABLE 154. UNITED KINGDOM GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, 2018-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 156. UNITED KINGDOM GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, 2018-2030 (USD MILLION)
TABLE 158. UNITED KINGDOM GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. UNITED KINGDOM GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 162. UNITED KINGDOM GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, 2018-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, 2018-2030 (USD MILLION)
TABLE 164. GERMANY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 165. GERMANY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2030 (USD MILLION)
TABLE 166. GERMANY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, 2018-2030 (USD MILLION)
TABLE 167. GERMANY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, 2018-2030 (USD MILLION)
TABLE 168. GERMANY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 169. GERMANY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 170. GERMANY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, 2018-2030 (USD MILLION)
TABLE 171. GERMANY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 172. GERMANY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. GERMANY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. GERMANY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 175. GERMANY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, 2018-2030 (USD MILLION)
TABLE 176. GERMANY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, 2018-2030 (USD MILLION)
TABLE 177. FRANCE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 178. FRANCE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2030 (USD MILLION)
TABLE 179. FRANCE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, 2018-2030 (USD MILLION)
TABLE 180. FRANCE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, 2018-2030 (USD MILLION)
TABLE 181. FRANCE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 182. FRANCE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 183. FRANCE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, 2018-2030 (USD MILLION)
TABLE 184. FRANCE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 185. FRANCE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. FRANCE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. FRANCE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 188. FRANCE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, 2018-2030 (USD MILLION)
TABLE 189. FRANCE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. RUSSIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. RUSSIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 201. RUSSIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, 2018-2030 (USD MILLION)
TABLE 202. RUSSIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, 2018-2030 (USD MILLION)
TABLE 203. ITALY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 204. ITALY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2030 (USD MILLION)
TABLE 205. ITALY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, 2018-2030 (USD MILLION)
TABLE 206. ITALY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, 2018-2030 (USD MILLION)
TABLE 207. ITALY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 208. ITALY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 209. ITALY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, 2018-2030 (USD MILLION)
TABLE 210. ITALY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 211. ITALY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. ITALY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. ITALY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 214. ITALY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, 2018-2030 (USD MILLION)
TABLE 215. ITALY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, 2018-2030 (USD MILLION)
TABLE 216. SPAIN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 217. SPAIN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2030 (USD MILLION)
TABLE 218. SPAIN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, 2018-2030 (USD MILLION)
TABLE 219. SPAIN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, 2018-2030 (USD MILLION)
TABLE 220. SPAIN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 221. SPAIN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 222. SPAIN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, 2018-2030 (USD MILLION)
TABLE 223. SPAIN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 224. SPAIN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. SPAIN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 226. SPAIN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 227. SPAIN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, 2018-2030 (USD MILLION)
TABLE 228. SPAIN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, 2018-2030 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 237. UNITED ARAB EMIRATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. UNITED ARAB EMIRATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. UNITED ARAB EMIRATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 240. UNITED ARAB EMIRATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, 2018-2030 (USD MILLION)
TABLE 241. UNITED ARAB EMIRATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, 2018-2030 (USD MILLION)
TABLE 242. SAUDI ARABIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2030 (USD MILLION)
TABLE 244. SAUDI ARABIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, 2018-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, 2018-2030 (USD MILLION)
TABLE 246. SAUDI ARABIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 248. SAUDI ARABIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, 2018-2030 (USD MILLION)
TABLE 249. SAUDI ARABIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 250. SAUDI ARABIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 251. SAUDI ARABIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 252. SAUDI ARABIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 253. SAUDI ARABIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, 2018-2030 (USD MILLION)
TABLE 254. SAUDI ARABIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, 2018-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 256. SOUTH AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, 2018-2030 (USD MILLION)
TABLE 258. SOUTH AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, 2018-2030 (USD MILLION)
TABLE 259. SOUTH AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 260. SOUTH AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 261. SOUTH AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGIC, 2018-2030 (USD MILLION)
TABLE 262. SOUTH AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 263. SOUTH AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. SOUTH AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 265. SOUTH AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
TABLE 266. SOUTH AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LOWER GI, 2018-2030 (USD MILLION)
TABLE 267. SOUTH AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY UPPER GI, 2018-2030 (USD MILLION)
TABLE 268. DENMARK GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 269. DENMARK GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2030 (USD MILLION)
TABLE 270. DENMARK GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, 2018-2030 (USD MILLION)
TABLE 271. DENMARK GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, 2018-2030 (USD MILLION)
TABLE 272. DENMARK GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 273. DENMARK GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TAB

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Gastrointestinal Bleeding Treatment Devices market report include:
  • Boston Scientific Corporation
  • Medtronic plc
  • Olympus Corporation
  • FUJIFILM Holdings Corporation
  • HOYA Corporation
  • Cook Medical LLC
  • Johnson & Johnson
  • B. Braun Melsungen AG
  • Teleflex Incorporated
  • ConMed Corporation

Table Information

Report AttributeDetails
No. of Pages195
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 590.93 Million
Forecasted Market Value ( USD ) by 2030 $ 765.86 Million
Compound Annual Growth Rate5.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Gastrointestinal Bleeding Treatment - Global Strategic Business Report - Product Image

Gastrointestinal Bleeding Treatment - Global Strategic Business Report

  • Report
  • 471 Pages
  • Global
From
Gastrointestinal Bleeding Treatment Devices Market Report 2025 - Product Image

Gastrointestinal Bleeding Treatment Devices Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Gastrointestinal Bleeding Treatment Market 2024-2028 - Product Image

Gastrointestinal Bleeding Treatment Market 2024-2028

  • Report
  • 134 Pages
  • Global
From
Abdominal Pain: Essential Diagnosis and Management in Acute Medicine - Product Image

Abdominal Pain: Essential Diagnosis and Management in Acute Medicine

  • Book
Dumping Syndrome Market Report 2025 - Product Image

Dumping Syndrome Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.